Patent Assignment
Reel/Frame 024749/0517
Assignment of Assignor's Interest
Recorded: 2010-07-27
Pages: 9
Assignors
REICHENBACHER, KATHARINA
Executed: 2010-04-24
DUGUID, ROBERT J.
Executed: 2010-04-27
PHILLIPSON, DOUGLAS
Executed: 2010-04-26
SIMSON, JACQUELINE A.
Executed: 2010-04-24
Assignee
TRIUS THERAPEUTICS
6310 NANCY RIDGE DR, SUITE 101, SAN DIEGO, CALIFORNIA, 92121
Covered Property
(1)
Crystalline Form of R)-3-(4-(2-(2-Methyltetrazol-5-Yl)Pyridin- 5-Yl)-3-Fluorophenyl)-5-Hydroxymethyl Oxazolidin-2-One Dihydrogen Phosphate
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Agreement
Nov 13, 2013
From: OPTIMER PHARMACEUTICALS, INC.; TRIUS THERAPEUTICS INC.
To: ROYAL BANK OF CANADA, AS ADMINISTRATIVE AGENT
Reel/Frame 031628/0850 →
Release of Security Interest
Jul 24, 2015
From: ROYAL BANK OF CANADA, AS ADMINISTRATIVE AGENT
To: TRIUS THERAPEUTICS, INC.; OPTIMER PHARMACEUTICALS, INC.
Reel/Frame 036178/0175 →
Change of Name
Sep 2, 2015
From: TRIUS THERAPEUTICS, INC.
To: TRIUS THERAPEUTICS LLC
Reel/Frame 036528/0029 →
Nunc Pro Tunc Assignment
Sep 3, 2015
From: TRIUS THERAPEUTICS LLC
To: MERCK SHARP & DOHME CORP.
Reel/Frame 036484/0796 →
Merger
Aug 8, 2022
From: MERCK SHARP & DOHME CORP.
To: MERCK SHARP & DOHME LLC
Reel/Frame 061102/0145 →